[1]
Grauer GF, Proteinuria: measurement and interpretation. Topics in companion animal medicine. 2011 Aug;
[PubMed PMID: 21782142]
Level 3 (low-level) evidence
[3]
Lamb EJ,MacKenzie F,Stevens PE, How should proteinuria be detected and measured? Annals of clinical biochemistry. 2009 May;
[PubMed PMID: 19389884]
[4]
Levey AS,Coresh J,Balk E,Kausz AT,Levin A,Steffes MW,Hogg RJ,Perrone RD,Lau J,Eknoyan G, National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of internal medicine. 2003 Jul 15;
[PubMed PMID: 12859163]
Level 1 (high-level) evidence
[5]
Verma V,Kant R,Sunnoqrot N,Gambert SR, Proteinuria in the elderly: evaluation and management. International urology and nephrology. 2012 Dec;
[PubMed PMID: 22826147]
[6]
Clase CM,Gao P,Tobe SW,McQueen MJ,Grosshennig A,Teo KK,Yusuf S,Mann JF, Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study. Annals of internal medicine. 2011 Mar 1;
[PubMed PMID: 21357908]
[7]
Astor BC,Matsushita K,Gansevoort RT,van der Velde M,Woodward M,Levey AS,Jong PE,Coresh J,Astor BC,Matsushita K,Gansevoort RT,van der Velde M,Woodward M,Levey AS,de Jong PE,Coresh J,El-Nahas M,Eckardt KU,Kasiske BL,Wright J,Appel L,Greene T,Levin A,Djurdjev O,Wheeler DC,Landray MJ,Townend JN,Emberson J,Clark LE,Macleod A,Marks A,Ali T,Fluck N,Prescott G,Smith DH,Weinstein JR,Johnson ES,Thorp ML,Wetzels JF,Blankestijn PJ,van Zuilen AD,Menon V,Sarnak M,Beck G,Kronenberg F,Kollerits B,Froissart M,Stengel B,Metzger M,Remuzzi G,Ruggenenti P,Perna A,Heerspink HJ,Brenner B,de Zeeuw D,Rossing P,Parving HH,Auguste P,Veldhuis K,Wang Y,Camarata L,Thomas B,Manley T, Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney international. 2011 Jun;
[PubMed PMID: 21289598]
Level 1 (high-level) evidence
[8]
Snyder S, John JS. Workup for proteinuria. Primary care. 2014 Dec:41(4):719-35. doi: 10.1016/j.pop.2014.08.010. Epub 2014 Sep 27
[PubMed PMID: 25439530]
[10]
Nielsen R,Christensen EI, Proteinuria and events beyond the slit. Pediatric nephrology (Berlin, Germany). 2010 May;
[PubMed PMID: 20049615]
[14]
Gurung R,Li T, Renal Amyloidosis: Presentation, Diagnosis, and Management. The American journal of medicine. 2022 Apr
[PubMed PMID: 35085515]
[15]
Kohler M,Schänzer W,Thevis M, Effects of exercise on the urinary proteome. Advances in experimental medicine and biology. 2015;
[PubMed PMID: 25355575]
Level 3 (low-level) evidence
[16]
Lim D,Lee DY,Cho SH,Kim OZ,Cho SW,An SK,Kim HW,Moon KH,Lee MH,Kim B, Diagnostic accuracy of urine dipstick for proteinuria in older outpatients. Kidney research and clinical practice. 2014 Dec;
[PubMed PMID: 26885477]
[17]
Tomonaga Y,Risch L,Szucs TD,Ambühl PM, The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study. PloS one. 2013;
[PubMed PMID: 23844110]
Level 2 (mid-level) evidence
[18]
White SL,Yu R,Craig JC,Polkinghorne KR,Atkins RC,Chadban SJ, Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2011 Jul;
[PubMed PMID: 21411199]
[19]
Bezinque A,Noyes SL,Kirmiz S,Parker J,Dey S,Kahnoski RJ,Lane BR, Prevalence of Proteinuria and Other Abnormalities in Urinalysis Performed in the Urology Clinic. Urology. 2017 May;
[PubMed PMID: 28212852]
[20]
Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, Makino H, Hishida A. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clinical and experimental nephrology. 2008 Feb:12(1):1-8. doi: 10.1007/s10157-007-0010-9. Epub 2008 Jan 5
[PubMed PMID: 18175065]
Level 3 (low-level) evidence
[21]
Jones CA,Francis ME,Eberhardt MS,Chavers B,Coresh J,Engelgau M,Kusek JW,Byrd-Holt D,Narayan KM,Herman WH,Jones CP,Salive M,Agodoa LY, Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002 Mar;
[PubMed PMID: 11877563]
Level 3 (low-level) evidence
[22]
Bryson CL,Ross HJ,Boyko EJ,Young BA, Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006 Nov;
[PubMed PMID: 17059991]
Level 3 (low-level) evidence
[23]
Liu D,Lv LL, New Understanding on the Role of Proteinuria in Progression of Chronic Kidney Disease. Advances in experimental medicine and biology. 2019;
[PubMed PMID: 31399981]
Level 3 (low-level) evidence
[24]
Gong R,Wang P,Dworkin L, What we need to know about the effect of lithium on the kidney. American journal of physiology. Renal physiology. 2016 Dec 1;
[PubMed PMID: 27122541]
[25]
Sfrijan D,Tieranu I,Necula I,Popa L,Balgradean M, Nephrotic Syndrome, Paraneoplastic Syndrome Associated to Hodgkin Lymphoma. Maedica. 2016 Mar;
[PubMed PMID: 28465754]
[26]
Leung AK,Wong AH,Barg SS, Proteinuria in Children: Evaluation and Differential Diagnosis. American family physician. 2017 Feb 15;
[PubMed PMID: 28290633]
[27]
Uva L,Miguel D,Pinheiro C,Freitas JP,Marques Gomes M,Filipe P, Cutaneous manifestations of systemic lupus erythematosus. Autoimmune diseases. 2012;
[PubMed PMID: 22888407]
[28]
Ağbaş A,Bay ED,Başaran MK,İkizceli T,Kayhan GK,Özlük Y, Nephrotic range proteinuria in an adolescent with a diagnosis of Wilson's disease: Answers. Pediatric nephrology (Berlin, Germany). 2021 Jul;
[PubMed PMID: 33528637]
[29]
WILLS MR,MCGOWAN GK, THE RELIABILITY OF THE ALBUSTIX TEST FOR PROTEINURIA. Journal of clinical pathology. 1963 Sep;
[PubMed PMID: 14063342]
[30]
Pugia MJ,Lott JA,Profitt JA,Cast TK, High-sensitivity dye binding assay for albumin in urine. Journal of clinical laboratory analysis. 1999;
[PubMed PMID: 10414598]
[31]
Vaziri ND, Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney international. 2016 Jul;
[PubMed PMID: 27165836]
[32]
Lindeman RD,Tobin J,Shock NW, Longitudinal studies on the rate of decline in renal function with age. Journal of the American Geriatrics Society. 1985 Apr;
[PubMed PMID: 3989190]
[33]
Ozkok A,Yildiz A, Hepatitis C virus associated glomerulopathies. World journal of gastroenterology. 2014 Jun 28;
[PubMed PMID: 24976695]
[34]
Lyubimova NV,Timofeev YS,Abaev VM,Votyakova OM,Kushlinskii NE, Immunochemical Diagnosis of Multiple Myeloma. Bulletin of experimental biology and medicine. 2018 May;
[PubMed PMID: 29797132]
[35]
Athavale A, Roberts DM. Management of proteinuria: blockade of the renin-angiotensin-aldosterone system. Australian prescriber. 2020 Aug:43(4):121-125. doi: 10.18773/austprescr.2020.021. Epub 2020 Aug 3
[PubMed PMID: 32921887]
[36]
Lewis EJ,Hunsicker LG,Bain RP,Rohde RD, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. The New England journal of medicine. 1993 Nov 11;
[PubMed PMID: 8413456]
[37]
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) Lancet (London, England). 1997 Jun 28;
[PubMed PMID: 9217756]
Level 1 (high-level) evidence
[38]
Bakris GL, Slowing nephropathy progression: focus on proteinuria reduction. Clinical journal of the American Society of Nephrology : CJASN. 2008 Jan;
[PubMed PMID: 18178794]
[39]
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002 Feb;
[PubMed PMID: 11904577]
Level 2 (mid-level) evidence
[40]
Yusuf S,Teo KK,Pogue J,Dyal L,Copland I,Schumacher H,Dagenais G,Sleight P,Anderson C, Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England journal of medicine. 2008 Apr 10;
[PubMed PMID: 18378520]
[41]
Pitt B,Zannad F,Remme WJ,Cody R,Castaigne A,Perez A,Palensky J,Wittes J, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England journal of medicine. 1999 Sep 2;
[PubMed PMID: 10471456]
Level 1 (high-level) evidence
[42]
Carmines PK, Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. The American journal of physiology. 1989 Jun:256(6 Pt 2):F1015-20
[PubMed PMID: 2544103]
[43]
Smith AC, Toto R, Bakris GL. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy. Kidney international. 1998 Sep:54(3):889-96
[PubMed PMID: 9734613]
[44]
Tanacan A,Fadiloglu E,Beksac MS, The importance of proteinuria in preeclampsia and its predictive role in maternal and neonatal outcomes. Hypertension in pregnancy. 2019 May;
[PubMed PMID: 30939965]
[45]
Tsampalieros A,Knoll GA, Evaluation and Management of Proteinuria After Kidney Transplantation. Transplantation. 2015 Oct;
[PubMed PMID: 26335919]
[46]
Reich HN,Troyanov S,Scholey JW,Cattran DC, Remission of proteinuria improves prognosis in IgA nephropathy. Journal of the American Society of Nephrology : JASN. 2007 Dec;
[PubMed PMID: 17978307]
[47]
Iimori S,Naito S,Noda Y,Sato H,Nomura N,Sohara E,Okado T,Sasaki S,Uchida S,Rai T, Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study. PloS one. 2018;
[PubMed PMID: 29342207]
[48]
Chen X,Chen Y,Ding X,Zhou Y,Lv Y,Li D,Chen B,Chen T,Chen C, Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy. Renal failure. 2019 Nov;
[PubMed PMID: 31057017]
[49]
Naderi AS, Reilly RF. Primary care approach to proteinuria. Journal of the American Board of Family Medicine : JABFM. 2008 Nov-Dec:21(6):569-74. doi: 10.3122/jabfm.2008.06.070080. Epub
[PubMed PMID: 18988725]
[50]
Perkovic V,Verdon C,Ninomiya T,Barzi F,Cass A,Patel A,Jardine M,Gallagher M,Turnbull F,Chalmers J,Craig J,Huxley R, The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS medicine. 2008 Oct 21;
[PubMed PMID: 18942886]
Level 1 (high-level) evidence
[51]
Ishigami J,Grams ME,Naik RP,Coresh J,Matsushita K, Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study. Clinical journal of the American Society of Nephrology : CJASN. 2016 Oct 7;
[PubMed PMID: 27515592]
[52]
Abbate M,Zoja C,Remuzzi G, How does proteinuria cause progressive renal damage? Journal of the American Society of Nephrology : JASN. 2006 Nov;
[PubMed PMID: 17035611]
[53]
Gigante A,Barbano B,Sardo L,Martina P,Gasperini ML,Labbadia R,Liberatori M,Amoroso A,Cianci R, Hypercoagulability and nephrotic syndrome. Current vascular pharmacology. 2014 May;
[PubMed PMID: 22724465]
[54]
Jun M,Ohkuma T,Zoungas S,Colagiuri S,Mancia G,Marre M,Matthews D,Poulter N,Williams B,Rodgers A,Perkovic V,Chalmers J,Woodward M, Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON. Diabetes care. 2018 Jan;
[PubMed PMID: 29079715]
Level 2 (mid-level) evidence